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Abstract: Oocyte activation is an important process triggered by fertilization 
that initiates embryonic development. However, parthenogenetic activation 
can occur either spontaneously or with chemical treatments. The LT/Sv 
mouse strain is genetically predisposed to spontaneous activation. LT oocytes 
have a cell cycle defect and are ovulated at the metaphase I stage instead of 
metaphase II. A thorough understanding of the female meiosis defects in this 
strain remains elusive. We have reported that AMP-activated protein kinase 
(PRKA) has an important role in stimulating meiotic resumption and 
promoting completion of meiosis I while suppressing premature 
parthenogenetic activation. Here we show that early activation of PRKA during 
the oocyte maturation period blocked chemically induced activation in B6SJL 
oocytes and spontaneous activation in LT/SvEiJ oocytes. This inhibitory effect 
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was associated with high levels of MAPK1/3 activity. Furthermore, stimulation 
of PRKA partially rescued the meiotic defects of LT/Sv mouse oocytes in 
concert with correction of abnormal spindle pole localization of PRKA and loss 
of prolonged spindle assembly checkpoint activity. Altogether, these results 
confirm a role for PRKA in helping sustain the MII arrest in mature oocytes 
and suggest that dysfunctional PRKA contributes to meiotic defects in 
LT/SvEiJ oocytes. 
Keywords: AMP-activated protein kinase, chemically induced activation, 
LT/SvEiJ strain, mouse, oocyte, spontaneous activation 
Introduction 
Mammalian oocytes initiate meiosis during embryonic 
development and become arrested at the dictyate stage of prophase I 
around the time of birth. Following a midcycle gonadotropin stimulus, 
oocytes within preovulatory follicles resume meiosis, complete 
maturation, and are ovulated at the metaphase II (MII) stage, where 
they remain until fertilization. Meiosis is driven by M-phase promoting 
factor (MPF), a dimer containing catalytic CDK1 and regulatory cyclin 
B1 subunits; MPF activity drops during polar body extrusion, then rises 
and stays elevated during MII arrest [1]. Binding of sperm triggers 
activation of the mature ovum, a series of events that includes calcium 
oscillations, completion of meiosis, release of cortical granules, and 
initiation of embryonic development [2, 3]. Calcium signaling is a 
universal component of fertilization in the animal kingdom [4]; in 
vertebrates, calcium oscillations are an essential feature of egg 
activation and trigger release from MII arrest [5, 6]. This arrest is 
controlled by cytostatic factor (CSF), which involves stabilization of 
maturation promoting factor by the c-Mos/MAPK1/3 pathway and 
suppression of the anaphase promoting complex (APC) by early mitotic 
inhibitor 2 (Emi2) [7]. Indeed, interrupting the c-Mos/MAPK1/3 
pathway leads to loss of MPF activity and premature egg activation [8–
10]; in addition, knockdown of Emi2 allows degradation of cyclin B of 
MPF and drives eggs into anaphase II [11, 12], mimicking the effect of 
sperm-induced calcium oscillations [13, 14]. 
Oocyte aging, chemical treatment, and the intrinsic quality of 
the oocyte are factors that can lead to mouse egg activation in the 
absence of sperm [15]. It is well known that freshly ovulated oocytes 
are resistant to activation but become prone to activation with 
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increased age and tenure in the oviducts [16–18]. Chemical 
treatments such as calcium ionophore [19, 20], phorbol ester [20–22], 
protein synthesis inhibitors [23, 24], ethanol [25–27], and heavy 
metals [28, 29] are well-characterized inducers of parthenogenesis in 
oocytes matured both in vivo and in vitro. There are strain-dependent 
differences in oocyte susceptibility to spontaneous maturation [30], 
while altering metabolism or length of hormonal priming can induce 
parthenogenesis in strains that normally exhibit very low rates of 
activation [31, 32]. 
The LT/Sv strain is an inbred recombinant mouse line derived 
from C58 and BALB strains whose oocytes fail to complete meiosis, 
leading to arrest at metaphase I [33–36], due to persistent MPF 
activity and a poor anaphase I trigger [36–39]. This MI arrest is 
associated with premature activation of oocytes within the ovary and a 
high incidence of ovarian teratomas [40–42]. The parthenotes advance 
to the egg cylinder stage, but further development is disrupted, with 
formation of a disorganized mass of differentiated cell types [40]. A 
significant number of LT/Sv oocytes are ovulated at the metaphase I 
stage, and this arrest appears necessary but not sufficient to induce 
parthenogenetic activation [43, 44]. Apparently, the protracted MI 
arrest brings about changes within the oocyte that predispose it to 
activation. The exact mutation(s) of the LT/Sv mouse remains 
unknown, but evidence suggests that the phenotype of LT/Sv oocytes 
is controlled by multiple alleles [42, 43]. 
We have previously demonstrated a role for AMP-dependent 
protein kinase (PRKA) in mouse oocyte maturation. This kinase is a 
critical regulator of metabolism and cell cycle that responds to changes 
in stress and energy deficit [45]. The activation of PRKA in mouse 
oocytes not only induces meiotic resumption [46–48] but also 
promotes first polar body (PB) formation [32]. Active PRKA localizes to 
chromosomes and the meiotic spindle poles during maturation [32], 
and this association pattern is dependent on spindle/microtubule 
integrity [49]. Moreover, blocking PRKA activity with the specific 
inhibitor compound C induces premature egg activation, whereas 
treatment with the PRKA activator AICAR suppresses the activation 
that occurs during spontaneous maturation of oocytes from unprimed 
and 1-day-primed mice [32]. This latter finding implicated PRKA in the 
regulation of activation in mouse oocytes. 
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In this study, we further examined the relationship between 
PRKA and oocyte activation. We report that PRKA activators suppress 
both chemically induced activation in oocytes from C57BL/6J×SJL F1 
(B6SJL) mice and spontaneous activation in oocytes from LT/SvEiJ 
mice during maturation in vitro but are less effective in ovulated B6SJL 
oocytes. This protection by PRKA was manifest during the oocyte 
maturation period and was associated with high levels of MAPK1/3 
activity and the accelerated loss of the spindle assembly checkpoint 
protein MAD2. Stimulation of PRKA in LT/SvEiJ oocytes rescued the “LT 
phenotype” by reducing the rate of parthenogenetic activation and 
promoting anaphase onset and PB formation. These data support a 
multifunctional role of PRKA in mouse oocytes and suggest that PRKA 
dysfunction may contribute to meiotic defects in LT/SvEiJ oocytes. 
Materials and Methods 
Chemicals 
Unless otherwise noted, chemicals were supplied by Sigma-
Aldrich Co. (St. Louis, MO). AICAR was from Toronto Research 
Chemicals, Inc. (North York, Ontario, Canada) and amphiregulin from 
R&D Systems (Minneapolis, MN). Highly purified ovine FSH was 
obtained from the National Hormone and Peptide Program and Dr. A.F. 
Parlow. Cy3-conjugated donkey anti-rabbit IgG was purchased from 
Jackson ImmmoResearch (West Grove, PA), Anti-phospho PRKA 
(PT172) antibody from Cell Signaling Technology (Beverly, MA), and 
rabbit anti-ERK1/2 and pERK1/2 (MAPK1/3) antibodies from Sigma. 
Anti-MAD2 antibody was a kind gift from Dr. E.D. Salmon (University 
of North Carolina). 
Oocyte Isolation and Culture Condition 
All procedures were approved by the Marquette University 
Institutional Animal Care and Use Committee. Immature, 20- to 23-
day-old C57BL/6J×SJL/J F1 (B6SJL) and LT/SvEiJ female mice were 
used for all experiments. Mice were primed with 5 IU equine chorionic 
gonadotropin (eCG), and oocytes were isolated 2 days later. For 
superovulation, 5 IU human chorionic gonadotropin (hCG) were 
administered IP 44–48 h post-eCG, and oocytes were isolated at 
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varying times thereafter. Mice were killed by cervical dislocation, and 
either ovaries or oviducts were removed and placed in a Petri dish 
containing culture medium. Cumulus cell-enclosed oocytes (CEO) were 
isolated by puncturing the follicles with sterile needles. Denuded 
oocytes (DO) were obtained by stripping cumulus cells with a mouth-
operated small-bore pipette. Oviducts were punctured with sterile 
needles to release the expanded cumulus masses, which were then 
treated briefly with hyaluronidase to remove cumulus cells. 
Both CEO and DO were washed twice and transferred to 
polystyrene round-bottom culture tubes (BD Falcon, Durham, NC) 
containing 1 ml of the appropriate test medium. The culture medium 
used was Eagle minimum essential medium (MEM) supplemented with 
penicillin, streptomycin sulfate, 0.23 mM sodium pyruvate, and 3 
mg/ml lyophilized crystallized bovine serum albumin (MP Biomedicals, 
Solon, OH). Calcium was omitted from the medium when activation 
was stimulated with strontium or calcium ionophore A23187. 
Chemical Activation 
Figure 1 depicts the three activation schemes used in this study. 
CEO or DO were cultured 17 h in control MEM prior to treatment with 
chemical activators. Cumulus cells were removed from CEO at the end 
of this initial culture period so that only DO received the activation 
stimulus. The three activation regimens are as follows: 
 
FIG. 1. Schematic diagram of activation protocols. For all treatment regimens, CEO or 
DO were first cultured 17 h in control medium to permit completion of maturation. 
When appropriate, cumulus cells were then removed from CEO, and DO were exposed 
to chemical activating conditions. A) Oocytes were treated with strontium in calcium-
free MEM for 2.5 h, washed, and then transferred to control MEM for 3.5 h. B) Oocytes 
were exposed to 7% ethanol for 7 min, washed, and then transferred to control MEM 
for 6 h. C) Oocytes were treated with A23187 for 5 min, washed, and then transferred 
to puromycin (Pur) for 6 h. 
1. Strontium. 2.5 h in calcium-free MEM containing 1 mM strontium, 
wash, and 3.5 h culture in control MEM. 
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2. A23187/puromycin. 5 min in control MEM containing 5 μM calcium 
ionophore A23187, wash, and 6 h culture in control MEM containing 10 
μg/ml puromycin. 
3. Ethanol. 7 min in control MEM containing 7% EtOH, wash, and 6 h 
culture in control MEM. 
CEO or DO were exposed to PRKA activators (0.2 mM AICAR, 2 mM 
AMP, or 2 μM RSVA405) during meiotic maturation (prematuration) or 
during/after the activation procedure (postmaturation). CEO were 
hormonally stimulated with 0.1 μg/ml FSH or 50 μg/ml amphiregulin 
during meiotic maturation. Oocytes were considered to be activated if 
they contained a pronucleus or two polar bodies with or without 
pronucleus or had undergone cleavage. 
Immunofluorescent Staining 
Cumulus cell-free oocytes were fixed with 4% formaldehyde in 
PBS at 4°C overnight. They were then permeabilized 30 min with 0.1% 
Triton-100 in blocking solution, which contained 10% donkey serum 
and 0.5 mg/ml saponin in PBS, followed by 1 h in blocking solution. 
Oocytes were incubated with primary antibody (1:100) overnight at 
4°C (either rabbit anti-pPRKAThr172 or rabbit anti-MAD2 antibody) and 
washed four times at room temperature in blocking buffer. This was 
followed by 1 h incubation with FITC-conjugated mouse anti-tubulin 
antibody (1:100) and Cy3-conjugated donkey anti-rabbit IgG antibody 
(1:100) at room temperature. Some oocytes were stained for actin 
using Alexa 568 Fluor phalloidin (Life Technologies, Grand Island, NY) 
during the secondary antibody culture period. Oocytes were washed 
four times, placed on slides, and mounted with medium containing 
DAPI (Vector Laboratories, Burlingame, CA). 
Confocal Microscopy 
Oocytes were observed on a laser scanning confocal microscope 
(Carl Zeiss Co., Thornwood, NY) with a 63× objective. During 
scanning, all settings were kept constant (i.e., laser power, detector 
gain, amplifier offset, amplifier gain, and pinhole size). Digitally 
recorded images were exported by LSM Examiner software (Carl 
Zeiss). 
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Western Blot Analysis 
Oocyte samples were washed with PBS/PVP, then twice with 
protease inhibitor cocktail (Roche, Indianapolis, IN). Samples were 
lysed by Laemmli buffer with 20% beta-mercaptoethanol at 95°C for 5 
min. Electrophoresis was carried out using NuPAGE 4–12% Bis-Tris 
Gels (InVitrogen, Carlsbad, CA), and proteins were transferred to 
nitrocellulose membranes. Membranes were blocked with 5% nonfat 
milk, followed by incubation with rabbit anti-pERK1/2 (pMAPK1/3) 
antibody (1:1000) at 4°C overnight. Blots were rinsed twice with TBS 
(pH 7.4) and once with TBS-Tween-20 (0.05%), followed by 
incubation with HRP-conjugated goat anti-rabbit IgG antibody (1:5000 
in 5% nonfat milk; Thermo Scientific Pierce, Rockford, IL) at room 
temperature for 1 h. After washing, protein signals were detected by 
super signal west pico chemiluminescent substrate (Thermo Scientific 
Pierce). Blots were stripped with restore Western blot stripping buffer 
(Thermo Scientific Pierce) at room temperature for 15 min and 
reprobed with rabbit anti-MAPK1/3 antibody (1:1000). The 
pMAPK1/3:MAPK1/3 ratios were quantified with ImageJ software based 
on protein band density. 
Statistical Analysis 
All experiments were repeated at least three times and data 
presented as mean ± SEM. Percentages of activation, polar body, or 
MAD2 staining underwent arcsin transformation, and data were 
analyzed statistically by analysis of variance followed by the Duncan 
multiple range test. Student t-test was used to compare paired 
treatments in some experiments. A P value < 0.05 was considered 
significant. 
Results 
Effects of PRKA Activators on Chemically Induced 
Activation in B6SJL Oocytes 
We have previously shown that the PRKA activator AICAR 
prevents premature activation in spontaneously activating oocytes 
from B6SJL mice when present during meiotic maturation [32]. To test 
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if PRKA stimulation would also block activation induced by chemical 
treatments, we adopted three different protocols depending on the 
agent(s) used to stimulate activation: strontium, A23187/puromycin, 
or ethanol. For all three treatments, CEO or DO were cultured 17 h in 
control MEM to allow for meiotic maturation. Remaining cumulus cells 
were then removed from CEO, and these cumulus cell-free oocytes as 
well as the mature DO were exposed to chemical activating conditions 
(Fig. 1). 
Strontium-induced activation.  
The first series of experiments utilized the activating agent 
strontium, and cultures were carried out in calcium-free medium since 
the absence of calcium has previously been demonstrated to augment 
activation by this agent [50]. After removing cumulus cells from 
matured CEO, oocytes were exposed to 1 mM strontium in calcium-
free MEM for 2.5 h, followed by 3.5 h incubation in control, calcium-
containing medium. In control oocytes not exposed to strontium, only 
4% were activated compared to 70% activation in strontium-treated 
oocytes (Fig. 2A). When 200 μM AICAR were included in both the 
activation and the postactivation media, a modest reduction in the 
activation percentage was observed (57%); however, when 
supplementation of AICAR was restricted to the initial 17 h oocyte 
maturation period, prior to strontium treatment, activation was 
reduced to 15% (Fig. 2A). In the next experiment, the direct effects of 
AICAR were tested on strontium activation of matured DO, utilizing the 
same protocol that was used with CEO. In the absence of cumulus 
cells, no activation was observed in the control group, but strontium 
stimulated 34–35% of the oocytes to activate. AICAR blocked 
strontium-induced activation, and the effect of exposure during meiotic 
maturation was comparable to that when exposure followed 
maturation (Fig. 2A). 
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FIG. 2. Effect of PRKA stimulators and hormones on strontium-induced activation. 
Treatment with AICAR (A), AMP (B), or RSVA405 (C) during oocyte maturation 
(prematuration) prevented strontium-induced activation in both CEO and DO, but 
supplementation after the 17-h maturation period (postmaturation) was relatively 
ineffective. D) Amphiregulin (AR) or FSH suppressed strontium-induced activation in 
CEO when present during the initial maturation period. E) Effect of delaying AICAR 
treatment on strontium-induced activation. The inhibitory effect of AICAR on activation 
in CEO was decreased when AICAR treatment was initiated 8 h but not 6 h after the 
start of culture. All data are presented as mean percent activated ± SEM. Groups with 
no common letter are significantly different (CEO, a–d; DO, w–z). 
AICAR is an analog of AMP, and when the experiment was repeated 
with native AMP, similar results were obtained. Exposure to AMP 
during oocyte maturation reduced the activation rate in CEO from 71% 
to 23% (compared to 4% in controls), whereas exposure to AMP 
postactivation had no effect (Fig. 2B). When the experiment was 
repeated in DO, a similar suppression of activation was obtained if AMP 
treatment occurred during the maturation period; however, 
surprisingly, treatment postmaturation with AMP increased the level of 
activation (Fig. 2B). 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biology of Reproduction, Vol 88(3), No. 70 (2013). DOI. This article is © Society for the Study of Reproduction and 
permission has been granted for this version to appear in e-Publications@Marquette. Society for the Study of 
Reproduction does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from Society for the Study of Reproduction. 
10 
 
A small-molecule PRKA activator has recently been described 
that is an analog of resveratrol, RSVA405 [51]. Supplementary 
experiments demonstrated that, like AICAR, RSVA405 promoted GVB 
and polar body formation, and its action was suppressed by the PRKA 
inhibitor compound C (Supplemental Fig. S1, available online at 
www.biolreprod.org). We therefore repeated the strontium activation 
experiments, using RSVA405 as the PRKA activator. Consistent with 
the AICAR and AMP results, RSVA405 suppressed strontium-induced 
activation in both CEO and DO at concentrations that stimulate meiotic 
resumption and polar body formation but was effective only when 
present during the initial maturation period (Fig. 2C). 
Both FSH and the EGF-like peptide amphiregulin (AR) are potent 
stimulators of meiotic maturation of mouse CEO in vitro, with 
downstream activation of oocyte PRKA preceding GVB [48]. We 
predicted that, because of their PRKA-stimulating capability, treatment 
of CEO with either of these peptides would block strontium-induced 
activation. For this experiment, FSH and AR were present only during 
the initial maturation period. These results are shown in Figure 2D. As 
predicted, FSH and AR reduced the activation rate, from 77% to 38% 
and 33%, respectively. 
Since the data indicate that early activation of PRKA within the 
oocyte is important for its protective effect on activation, an 
experiment was conducted in which exposure of CEO to AICAR was 
delayed during the maturation period to determine the required 
temporal exposure to achieve maximum protection. There was no loss 
of protection when exposure to AICAR was delayed by 6 h; however, 
delaying AICAR treatment by 8 h reduced its protective effect by 27% 
(Fig. 2E). This suggests that maximum protection requires exposure 
within 6 h of the initiation of culture, a time point corresponding to the 
early stages of spindle formation. 
Since the cMos-MAPK1/3 pathway is important for maintaining 
MII arrest [8–10], we tested the effect of PRKA activation in CEO on 
MAPK1/3 activity following strontium activation. Oocytes were 
collected for Western blot at 17 h (after maturation), 19.5 h 
(poststrontium treatment), and 23 h (after final recovery). As shown 
in Figure 3, control oocytes that were treated with calcium-free 
medium alone maintained a high level of MAPK1/3 activity at all three 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biology of Reproduction, Vol 88(3), No. 70 (2013). DOI. This article is © Society for the Study of Reproduction and 
permission has been granted for this version to appear in e-Publications@Marquette. Society for the Study of 
Reproduction does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from Society for the Study of Reproduction. 
11 
 
time points. In contrast, oocytes that were treated with strontium 
exhibited decreased MAPK1/3 activity after the second and third 
culture periods. Consistent with their preventive effect on activation, 
both AMP- and AICAR-treated oocytes maintained high MAPK1/3 
activity at all time points tested. 
 
FIG. 3. Maintenance of MAPK1/3 activity in oocytes treated with AICAR (AIC) or AMP 
during maturation. A) Representative Western blot analysis of p-MAPK1/3 in oocytes 
treated as described in Figure 1A. Denuded oocyte extracts were subjected to Western 
blot analysis at the end of each of the three treatment phases. +/− in the second 
culture indicates the presence or absence of strontium. Con, control. B) Quantitative 
analysis of pMAPK1/3 signals from Western blot, presented as a ratio of the band 
intensity of pMAPK1/3 to that of nonphosphorylated MAPK1/3. Mean ± SEM of three 
blots. Treatments with either AICAR or AMP maintained high pMAPK1/3 levels that 
were comparable to the control group. Data are presented as mean ratio ± SEM. 
 
A23187/puromycin-induced activation.  
CEO were used to test the ability of AICAR to reverse the 
activation resulting from sequential treatment of calcium ionophore 
A23187 followed by the protein synthesis inhibitor puromycin. Mature 
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oocytes were cultured 5 min in 5 μM calcium ionophore A23187 
followed by 6 h in 10 μg/ml puromycin (Fig. 1). In the control group 
treated with ionophore alone, only 12% of the oocytes underwent 
activation (Fig. 4A). When ionophore-treated oocytes were 
subsequently exposed to puromycin, the activation rate was increased 
to 66%. If oocytes were exposed to AICAR during puromycin 
exposure, there was no significant reduction in activation (43%); 
however, a significant decrease occurred when AICAR was present 
during the initial maturation period (31% activation; Fig. 4A). 
 
FIG. 4. Treatment with AICAR during but not following oocyte maturation blocked 
A23187/puromycin-induced (A) and ethanol-induced (B) activation in CEO. Data are 
presented as mean percent activated ± SEM. Groups with no common letter are 
significantly different. 
 
Ethanol-induced activation.  
CEO were used to test the effect of AICAR on ethanol-induced 
activation. When oocytes were exposed for 7 min to 7% ethanol 
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followed by 6 h culture in control medium (Fig. 1), 78% of the oocytes 
underwent activation compared to 1% of controls (Fig. 4B). If CEO 
were treated with AICAR during the initial maturation period, ethanol-
induced activation was reduced by 54%, while restricting AICAR 
treatment to the last 6 h had no effect. 
Effect of PRKA Activation on In Vivo-Aged B6SJL 
Oocytes 
It has been well documented that increased aging of ovulated 
oocytes within the oviduct increases their susceptibility to spontaneous 
activation [16–18]. This was confirmed when eggs were retrieved from 
the oviducts of superovulated B6SJL mice 16, 20, and 24 h post-hCG 
and cultured 6 h in control medium. The percentage of activation 
increased in direct relationship to the time post-hCG the eggs were 
retrieved (2%, 12%, and 32% activation, respectively); there was a 
modest trend for suppression of activation at all time points when 
AICAR was present during 6 h culture (0%, 8%, and 22% activation, 
respectively; Fig. 5). 
 
FIG. 5. Effect of PRKA on activation of in vivo-matured oocytes. Oocytes were 
retrieved from oviducts 16, 20, and 24 h post-hCG and cultured 6 h with or without 
AICAR. Although there was a trend toward less activation in AICAR-treated oocytes, 
differences were not significant. Data are presented as mean percent activated ± SEM. 
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Effects of PRKA Activators on Oocyte Activation in the 
LT/SvEiJ Strain 
Oocytes from the LT/Sv mouse strain exhibit a high rate of 
spontaneous activation [43]. It was therefore important to determine 
if PRKA activators would also suppress this type of oocyte activation. 
We initially compared spontaneous activation rates in oocytes from 
B6SJL and LT/SvEiJ (hereafter designated LT) mice following 30 h 
culture in the presence or absence of AICAR. In the absence of AICAR, 
activation rates were 2% and 21%, respectively, while AICAR reduced 
these rates to 0% and 4% (Fig. 6A). When LT CEO were treated with 
RSVA405, a similar reduction in activation was observed (Fig. 6B). 
 
FIG. 6. Effects of PRKA stimulation on LT/SvEiJ oocytes. A) AICAR blocked 
spontaneous activation in LT oocytes during 30 h cultures. B) RSVA405 had a similar 
inhibitory action on LT activation. Asterisks in A and B denote a significant difference 
from controls (Con). C) AICAR blocked activation in LT oocytes when present during 
but not after oocyte maturation. LT/Sv oocytes were first cultured in control MEM 
(Con) or AICAR for 17 h and then transferred to control or AICAR-supplemented 
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medium for another 13 h before activation was assessed. A different letter denotes a 
significant difference. D) AICAR stimulated PB formation in both B6SJL and LT oocytes 
during 17 h cultures. An asterisk denotes a significant difference from controls (Con). 
Data in A–D are presented as percent activation or PB ± SEM. E and F) pPRKA (PT172) 
localization (E) and stage of meiosis (F) in MI stage oocytes after 8 h of culture. AICAR 
increased the percentage of normal PT172 spindle pole localization in LT oocytes and 
increased the percentage of anaphase I (Ana) in oocytes from both the B6SJL and LT 
strains. Pro, prometaphase. 
To determine the temporal window for AICAR exposure that 
protects the LT oocyte from activation, oocytes were first cultured in 
control medium or medium containing AICAR for 17 h, then 
transferred to control MEM or AICAR-supplemented medium for an 
additional 13 h before activation was assessed. As shown in Figure 6C, 
high levels of activation were observed in the control/control or 
control/AICAR oocyte groups, while significantly lower levels of 
activation were observed in the AICAR/AICAR and AICAR/control 
groups. These results are consistent with earlier experiments in B6SJL 
oocytes showing a protective effect of AICAR during the initial period 
of oocyte maturation. 
In addition to high rates of spontaneous activation, LT oocytes 
also fail to progress past metaphase I both in vivo and during 
spontaneous maturation in vitro [33, 38, 52]. Thus, we tested whether 
PRKA stimulation could overcome this meiotic defect. CEO from B6SJL 
and LT mice were cultured in either control or AICAR-containing 
medium for 17 h and assessed for polar body formation. In B6SJL 
oocytes, 53% formed polar bodies in control medium, while AICAR 
increased this number to 78% (Fig. 6D). No polar bodies were 
observed in LT oocytes cultured in control medium, but 22% of AICAR-
treated oocytes extruded a polar body. 
When LT oocytes were stained for active PRKA after 17 h culture 
in control medium, we observed a high incidence of abnormal 
localization. Instead of staining at both spindle poles, which is the 
typical staining pattern in B6SJL oocytes, in most LT oocytes the 
localization was either shifted away from the poles or absent at one or 
both of the poles (data not presented). Since LT oocytes are arrested 
at MI for a prolonged period of time, to eliminate the possibility that 
this phenotype was due to an aging effect, we stained oocytes for 
active PRKA after 8 h in both B6SJL and LT strains, when MI has been 
freshly established, and compared MI localization patterns between the 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biology of Reproduction, Vol 88(3), No. 70 (2013). DOI. This article is © Society for the Study of Reproduction and 
permission has been granted for this version to appear in e-Publications@Marquette. Society for the Study of 
Reproduction does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from Society for the Study of Reproduction. 
16 
 
two strains. Seventy-five percent of B6SJL MI-stage oocytes cultured 
in control medium exhibited active PRKA at both spindle poles (Figs. 
6E, E,7A).7A). However, only 28% of LT MI-stage oocytes had similar 
bipolar staining, (Figs. 6E, E,7B,7B, and 7C). Treatment with AICAR 
had no effect in B6SJL oocytes but doubled the percentage of LT 
oocytes with normal PRKA staining (57%). 
 
FIG. 7. A–C) Immunofluorescent staining of active PRKA in LT oocytes. A) Normal 
spindle pole localization of active PRKA. B) Shifted spindle pole localization. C) Missing 
spindle pole localization. Green, α-tubulin; red, pPRKAThr172; blue, DAPI. D–G) 
AICAR treatment accelerated loss of MAD2 in kinetochores. D) Kinetics of centromeric 
MAD2 loss in B6SJL oocytes in the presence or absence of AICAR. E) AICAR treatment 
eliminated prolonged MAD2 kinetochore localization in LT oocytes. The data in D and E 
are presented as percent positive MAD2 stain ± SEM; the asterisk denotes a significant 
difference from −AICAR controls. F and G) MAD2 stain in LT oocytes that were 
cultured 8 h in control (F) or AICAR-supplemented (G) medium. Red, MAD2; blue, 
DAPI. 
A comparison of meiotic status in these same oocytes showed 
that 97% of B6SJL oocytes cultured 8 h in control medium reached 
prometaphase or metaphase I, with 3% in anaphase (Fig. 6F). 
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Similarly, 100% of LT oocytes were at metaphase I or prometaphase. 
The addition of AICAR accelerated meiotic progression such that 71% 
of B6SJL oocytes were at anaphase or beyond after 8 h of culture. In 
addition, 33% of LT oocytes were at anaphase after exposure to 
AICAR, which, along with the polar body data above, demonstrates 
AICAR-induced rescue from metaphase arrest in a significant 
percentage of the oocytes. 
AICAR Promotes the Loss of Chromosomal MAD2 
Staining 
Hupalowska et al. [53] previously reported that prolonged 
spindle assembly checkpoint (SAC) activity contributes to MI arrest in 
LT oocytes. To test the hypothesis that stimulation of PRKA promotes 
anaphase onset by overcoming SAC activity, oocytes were stained for 
MAD2, one of the major components of SAC [54]. We first determined 
the kinetics of centromeric MAD2 loss in B6SJL CEO (Fig. 7D). 
Although MAD2 staining intensity was reduced in control oocytes by 6 
h, 95% of them still remained positive. Between 6 and 8 h, the 
number of MAD2-positive oocytes decreased by 50%. AICAR treatment 
accelerated the loss of MAD2, with only 61% and 23% positively 
staining oocytes at 6 and 8 h, respectively. In LT CEO, 98% stained 
positive for MAD2 after 8 h of culture, whereas in the AICAR-treated 
group, it was reduced to 41% (Fig. 7, E, F, and G). 
Discussion 
In this study, we demonstrate the suppressive effects of PRKA 
on parthenogenetic activation in mouse oocytes. Stimulation with the 
PRKA activators AICAR, AMP, or RSVA405 during oocyte maturation 
prevented both chemically induced activation in B6SJL mice and 
spontaneous activation in LT mice, while exposure of oocytes to these 
agents after maturation had little effect on either type of activation. 
Stimulating PRKA in ovulated, in vivo-matured B6SJL eggs was 
relatively ineffective in preventing activation, likely due to the fact that 
the eggs were already mature at the time of treatment. Additional 
effects of PRKA activation on LT oocytes included changes in active 
PRKA localization, release from metaphase arrest, and a reduction in 
spindle checkpoint activity. 
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Treatment of mouse oocytes with strontium produces repetitive 
calcium oscillations that mimic the effect of sperm binding, making it 
one of the most effective chemical activating agents [20, 50, 55, 56]. 
Nevertheless, exposure to AICAR, AMP or RSVA405 was sufficient to 
block strontium-induced activation in both CEO and DO, indicating a 
direct action on the oocyte. Twice as many oocytes were activated in 
CEO compared to DO, confirming that the presence of cumulus cells 
during the maturation period promotes activation [57, 58]. The 
protection by AMP and AICAR was associated with maintenance of 
MAPK1/3 phosphorylation, which suggests that PRKA may prevent 
activation by blocking dephosphorylation of MAPK1/3 and keeping MPF 
activity high [7]. Activating the cMos/MAPK1/3 pathway in vertebrate 
oocytes can induce a CSF arrest [59, 60], while treating oocytes with 
inhibitors of MAP2K1 (MEK1), the immediate upstream MAPK1/3 
kinase, alleviates metaphase arrest and stimulates activation [9, 61]. 
Because treatment with PRKA activator and strontium were temporally 
separated, it is possible that this action of PRKA may reflect an indirect 
upstream effect, preventing an activation stimulus that acts on the 
MAPK1/3 pathway. Strontium-induced oocyte activation involves the 
interaction of phospholipase and InsP3 receptor [62], and it is possible 
that PRKA activation also interferes with these processes [63]. 
Calcium ionophore A23187 and protein synthesis inhibitors 
alone each modestly stimulate oocyte activation, but when oocytes are 
treated sequentially with these two agents, synergistic activation is 
observed [55, 64–66]. Brief exposure to ethanol is also an effective 
trigger for parthenogenetic activation [56, 67, 68]. Though both 
treatment regimens cause only single calcium transients, they still 
bring about significant levels of activation, and this was confirmed in 
the present study, with activation frequencies comparable to those 
achieved with strontium. More important, PRKA activators suppressed 
both A23187/puromycin- and ethanol-induced activation with a 
potency resembling that for strontium-treated oocytes. These results 
are important because they demonstrate a consistent activation-
suppressing response to PRKA stimulation regardless of the type of 
chemical activating stimulus. 
Chemically induced parthenogenesis was also suppressed by 
hormonal stimulation. The action of FSH and AR in CEO may be 
mediated by PRKA within the oocyte because we have previously 
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shown that these ligands activate the oocyte kinase in stimulated CEO 
[48]. However, it should also be noted that, under such stimulation, 
the CEO activation rate was only partially reduced to the level of DO. 
Thus, it is also possible that the proactivation cumulus cell influence is 
neutralized by hormone-triggered uncoupling of the oocyte from gap 
junction-mediated cumulus signals [57], thereby rendering it a 
physiologically denuded oocyte that is less sensitive to strontium 
stimulation. 
PRKA activation during oocyte maturation was essential for 
optimal protection from chemically induced activation; later treatment 
with PRKA activators during either the activation or the recovery 
period was largely ineffective. This relationship was very consistent for 
CEO. However, for DO, while prematuration exposure to PRKA 
activators was always inhibitory, the results of postmaturation 
treatment on activation varied between treatment groups: RSVA405 
had no effect, AICAR was inhibitory, and, curiously, AMP was 
stimulatory. The reason for these differences is not readily apparent 
but could relate to the comparative potency of the treatments in the 
presence or absence of the cumulus cells, or perhaps in the case of 
AMP there are additional direct actions on the oocyte unrelated to 
PRKA activity. This need for PRKA activity during oocyte maturation to 
safeguard against activation is consistent with our in vivo oocyte 
maturation data since AICAR only marginally prevented the 
spontaneous activation of oocytes when exposure occurred after they 
completed maturation in vivo. Further, the AICAR timing experiment 
showed that treatment with kinase activator could be delayed up to 6 
h after the initiation of culture and still achieve full protection against 
activation, a time point that roughly corresponds to metaphase spindle 
formation. After 6 h, physiological changes begin to manifest in the 
oocyte that make it more susceptible to activating conditions that 
PRKA activators cannot overcome. Interestingly, this temporal 
sensitivity is different than that for PRKA promotion of PB formation, 
which requires earlier exposure to PRKA activators, around the time of 
GVB [32]. Thus, PRKA not only induces initiation of meiotic resumption 
and promotes PB but also suppresses oocyte activation, though the 
data suggest its action is required at different time points during the 
maturation period to achieve these effects. 
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Most LT oocytes are unable to complete meiosis in a timely 
fashion, arresting at the MI stage [33–36], and this meiotic 
attenuation is important in the spontaneous activation phenotype [43]. 
Exposure to PRKA activators was not only effective against chemically 
induced activation in B6SJL oocytes but also blocked the spontaneous 
activation of LT oocytes; again, the PRKA activity was needed during 
the initial maturation period for optimal protection. Based on results of 
the Western blot analysis of MAPK1/3 phosphorylation in B6SJL 
oocytes, it is reasonable to propose that PRKA also suppressed 
MAPK1/3 dephosphorylation in LT oocytes and sustained elevated MPF 
activity that protected against activation. Consistent with this idea, 
MAPK1/3 activity remains high in LT oocytes throughout the period of 
MI arrest [35]. Activation of PRKA could prevent the loss of this 
activity and the escape from MI arrest that accompanies activation. 
Hirao and Eppig [38, 39] suggested a role for CSF in the prolonged MI 
arrest in LT oocytes; however, in wild-type oocytes, high CSF activity 
did not initiate the MI arrest but only delayed the metaphase-to-
anaphase transition, which suggested that CSF is not the primary 
cause of metaphase I arrest in this strain, though it may help maintain 
it. 
If the MI arrest in LT oocytes is, indeed, linked to 
parthenogenesis, then it is not surprising that PRKA also stimulated 
meiotic progression past this arrest point. To further address possible 
downstream mediators of PRKA, we investigated whether PRKA altered 
spindle assembly checkpoint (SAC) dynamics. SAC is a surveillance 
mechanism that monitors the integrity of the meiotic spindle and 
proper attachment of chromosomes to spindle microtubules and 
controls activation of the APC [69–71]. MAD2 is a SAC protein in 
mouse and rat oocytes that localizes to unattached kinetochores, 
sequestering the main component of APC, Cdc20, thereby inhibiting 
APC activity and keeping MPF activity high [72, 73]. MAD2 is required 
in mouse oocytes for maintaining MI and preventing premature 
anaphase [73–75], and similar involvement in the prolonged MI arrest 
in LT oocytes was recently reported [53, 76]. Also, as LT oocytes [53] 
or mice [77] age, the MI arrest weakens, coincident with declining SAC 
activity. We have shown herein that AICAR activation stimulated the 
loss of chromatin MAD2 staining, in concert with promoting anaphase 
onset. It is therefore likely that PRKA activator-induced loss of MAD2 
kinetochore binding contributes to both its acceleration of meiosis in 
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B6SJL oocytes and rescue of LT oocytes from MI arrest and activation. 
Whether the action of PRKA on MAD2 dynamics is direct or indirect and 
whether the mechanisms involved in the two strains are identical 
remain to be determined. 
Ciemerych and Kubiak [36] proposed that the lack of an 
appropriate anaphase I trigger in LT oocytes may be the critical 
determinant of the extended MI arrest. AICAR and, presumably, PRKA 
stimulation provided such a trigger in the present study. Our data 
support an alternative mechanism for PRKA action in which stimulation 
of meiotic progression past MI—for example, by altering MAD2 binding 
dynamics—eliminates the attenuated maturation that is essential for 
activation such that oocytes driven past MI fail to activate. Indeed, on 
treatment of LT oocytes with AICAR, the reduction in activation (18%; 
Fig. 6A) was offset by the number of oocytes that progress to MII 
(21%; Fig. 6D). Hence, it is tempting to speculate that the LT oocytes 
that would have activated in the absence of AICAR are those same 
oocytes stimulated to reach MII in its presence and that the nearly 
complete suppression of activation is due to meiotic escape from MI. 
Why the remaining MI-arrested oocytes do not activate is not clear, 
but it appears that only about one-fifth of the LT oocytes are prone to 
activation in our culture conditions. 
Curiously, the percentage of PRKA-treated LT oocytes that 
entered anaphase (33%) was higher than the number extruding a PB 
(21%). This suggested that karyokinesis occurred in the absence of 
cytokinesis in a small population of these oocytes. Indeed, when we 
stained actin filaments with phalloidin, 4% of AICAR-treated oocytes 
after 17 h of culture contained separated homologous chromosomes 
with a MII spindle yet no sign of a PB or contractile ring (data not 
shown). It is also possible that a small number of oocytes had 
segregated homologous chromosomes that reaggregated after 
anaphase onset [78, 79]. Furthermore, myosin regulatory light chain 
(MRLC), an important protein involved in the regulation of contractile 
ring formation, has recently been shown to be a downstream target of 
PRKA [80–82]. It would be interesting to see if MRLC localization and 
function is affected in LT oocytes and how it is related to the partial 
rescue of meiosis I arrest by AICAR. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biology of Reproduction, Vol 88(3), No. 70 (2013). DOI. This article is © Society for the Study of Reproduction and 
permission has been granted for this version to appear in e-Publications@Marquette. Society for the Study of 
Reproduction does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from Society for the Study of Reproduction. 
22 
 
When LT oocytes were stained for active PRKA after 8 h of 
culture, abnormal localization was frequently observed. This was not 
due to an aging effect following prolonged MI arrest because it was 
observed in oocytes with newly formed meiotic spindles. Although 
some B6SJL oocytes also showed abnormal spindle pole localization, it 
was much less frequent. Importantly, supplementation of AICAR 
significantly lowered the incidence of PRKA mislocalization in LT 
oocytes, which suggests that LT oocytes may have insufficient PRKA 
function. It has been reported that metaphase I-arrested LT oocytes 
have more organized centrosomal material on one spindle pole than 
the other [83]. This could help explain the missing or shifted spindle 
pole localization of active PRKA in these oocytes since active PRKA 
colocalizes with microtubule organizing centers [49]. 
Our results support the possibility that defective control of PRKA 
activity contributes to the LT phenotype. Genes for the two PRKA 
catalytic subunits, Prkaa1 and Prkaa2, are located on mouse 
chromosomes 15 and 4, respectively. However, a whole genome scan 
determined that regions in chromosome 1 and 9 were likely 
responsible for LT oocyte defects [44]. It may be that dysregulation of 
PRKA is a downstream consequence of abnormal genetic control in 
these regions. Regardless, it is apparent that PRKA has a profound 
influence on meiotic progression and regulation of parthenogenetic 
activation in both B6SJL and LT oocytes. Up to this point, our 
experiments have depended largely on pharmacological manipulation 
of PRKA, and genetic ablation experiments are needed for 
confirmation. Both isoforms of the catalytic subunit have been knocked 
out in mice, and each is viable and able to reproduce; however, the 
double knockout is an embryonic lethal [84]. It will be important to 
eliminate both isoforms in the oocyte to determine if PRKA is a 
requisite player or merely serves to fine-tune these physiological 
processes. We are currently in the process of generating PRKA-null 
oocytes to test this. 
Supplementary Material 
Supplemental Data:  
Supplemental Figure S1. Effects of RSVA405 on oocyte maturation. A) CEO 
or DO were cultured 17-18 h in medium containing 300 μM dibutyryl cyclic 
adenosine monophosphate plus increasing concentrations of RSVA405 before 
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assessing germinal vesicle breakdown (GVB). Meiotic resumption was induced 
in both groups of oocytes (by 25% in DO and 73% in CEO). B) CEO were 
cultured 17-18 h in dbcAMP alone or with additional supplements of 2 μM 
RSVA405 ± 2.5 μM compound C (PRKA inhibitor). The inhibitor completely 
blocked RSVA40s-induced maturation. C) CEO were cultured 15-16 h in 
control medium containing increasing concentrations of RSVA405 and 
assessed for polar body formation. The drug stimulated polar body formation 
in dose-dependent fashion. Data are presented as mean percent GVB or polar 
body (PB) ± SEM. For B and C, groups with no common letter are significantly 
different. 
Acknowledgment 
The authors are indebted to Dr. E.D. Salmon for supplying the 
anti-MAD2 antibody. 
Footnotes 
1Supported by a National Institutes of Health grant (R15 HD061858 to 
S.M.D.). Presented in part at the 44th Annual Meeting of the Society 
for the Study of Reproduction, 31 July–4 August 2011, Portland, 
Oregon. 
2Correspondence: Stephen M. Downs, Department of Biological Sciences, 
Marquette University, Milwaukee, WI 53233. E-mail: 
Stephen.downs@marquette.edu 
References 
1Jones KT. Turning it on and off: M-phase promoting factor during meiotic 
maturation and fertilization. Mol Hum Reprod 2004; 10: 1 5. 
2Horner VL, Wolfner MF. Transitioning from egg to embryo: triggers and 
mechanisms of egg activation. Dev Dyn 2008; 237: 527 544. 
3Wakai T, Vanderheyden V, Fissore RA. Ca2+ signaling during mammalian 
fertilization: requirements, players, and adaptations. Cold Spring Harb 
Perspect Biol 2011; 3 (4): 1 23. 
4Stricker SA. Comparative biology of calcium signaling during fertilization and 
egg activation in animals. Dev Biol 1999; 211: 157 176. 
5Malcuit C, Kuokawa M, Fissore RA. Calcium oscillations and mammalian egg 
activation. J Cell Physiol 2006; 206: 565 573. 
6Ducibella T, Fissore RA. The roles of Ca2+, downstream protein kinases, and 
oscillatory signaling in regulating fertilization and the activation of 
development. Dev Biol 2008; 315: 257 279. 
7Madgwick S, Jones KT. How eggs arrest at metaphase II: MPF stabilisation 
plus APC/C inhibition equals Cytostatic Factor. Cell Division 2007; 2: 4 
11. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biology of Reproduction, Vol 88(3), No. 70 (2013). DOI. This article is © Society for the Study of Reproduction and 
permission has been granted for this version to appear in e-Publications@Marquette. Society for the Study of 
Reproduction does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from Society for the Study of Reproduction. 
24 
 
8College WH, Carlton MBL, Udy GB, Evans MJ. Disruption of c-mos causes 
parthenogenetic development of unfertilized mouse eggs. Nature 
1994; 370: 65 68. 
9Hashimoto N, Watanabe N, Furuta Y, Tamemoto H, Sagata N, Yokoyama M, 
Okazaki K, Nagayoshi M, Takedat N, Ikawatll Y, Aizawai S. 
Parthenogenetic activation of oocytes in c-deficient mice. Nature 1994; 
370: 68 71. 
10Phillips KP, Petrunewich MAF, Collins JL, Booth RA, Liu XJ, Baltz JM. 
Inhibition of MEK or cdc2 kinase parthenogenetically activates mouse 
eggs and yields the same phenotypes as Mos−/− parthenogenotes. 
Dev Biol 2002; 247: 210 223. 
11Shoji S, Yoshida N, Amanai M, Ohgishi M, Fukui T, Fujimoto S, Nakano Y, 
Kajikawa E, Perry ACF. Mammalian Emi2 mediates cytostatic arrest 
and transduces the signal for meiotic exit via Cdc20. EMBO J 2006; 
25: 834 845. 
12Madgwick S, Hansen DV, Levasseur M, Jackson PK, Jones KT. Mouse Emi2 is 
required to enter meiosis II by reestablishing cyclin B1 during 
interkinesis. J Cell Biol 2006; 174: 791 801. 
13Nixon VL, Levasseur M, McDougall A, Jones KT. Ca(2+) oscillations promote 
APC/C-dependent cyclin B1 degradation during metaphase arrest and 
completion of meiosis in fertilizing mouse eggs. Curr Biol 2006; 12: 
746 750. 
14Suzuki T, Suzuki E, Yoshida N, Kubo A, Li H, Okuda E, Amanai M, Perry CF. 
Mouse Emi2 as a distinctive regulatory hub in second meiotic 
metaphase. Development 2010; 137: 3281 3291 
15Kaufman MH. Early Mammalian Development: Parthenogenetic Studies. 
London: Cambridge University Press; 1983.  
16Marston J, Chang M. The fertilizable life of ova and their morphology 
following delayed insemination in mature and immature mice. J Exp 
Zool 1964; 155: 237 251. 
17Kubiak JZ. Mouse oocytes gradually develop the capacity for activation 
during the metaphase II arrest. Dev Biol 1989; 136: 537 545. 
18Xu Z, Abbott A, Kopf GS, Schultz RM, Ducibella T. Spontaneous activation of 
ovulated mouse eggs: time-dependent effects on M-phase exit, cortical 
granule exocytosis, maternal messenger ribonucleic acid recruitment, 
and inositol 1,4,5-trisphosphate sensitivity. Biol Reprod 1997; 57: 743 
750. 
19Steinhardt RA, Epel D, Darroll EJ, Yanagimachi R. Is calcium ionophore a 
universal activator for unfertilized eggs? Nature 1974; 252: 41 43. 
20Uranga JA, Pedersen RA, Arechaga J. Parthenogenetic activation of mouse 
oocytes using calcium ionophores and protein kinase C stimulators. Int 
J Dev Biol 1996; 40: 515 519. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biology of Reproduction, Vol 88(3), No. 70 (2013). DOI. This article is © Society for the Study of Reproduction and 
permission has been granted for this version to appear in e-Publications@Marquette. Society for the Study of 
Reproduction does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from Society for the Study of Reproduction. 
25 
 
21Cuthbertson KSR, Cobbold PH. Phorbol ester and sperm activate mouse 
oocytes by inducing sustained oscillations in cell Ca2+. 1985; Nature 
316: 541 542. 
22Sun Q-Y, Rubinstein S, Breitbart H. MAP kinase activity is downregulated by 
phorbol ester during mouse oocyte maturation and egg activation in 
vitro. Mol Reprod Dev 1999; 52: 310 318. 
23Siracusa G, Whittingham DG, Molinaro M, Vivarelli E. Parthenogenetic 
activation of mouse oocytes induced by inhibitors of protein synthesis. 
J Embryol Exp Morphol 1978; 43: 157 166. 
24Fulka J Jr, Moor R, Fulka J. Sister chromatid separation and the metaphase-
anaphase transition in mouse oocytes. Dev Biol 1994; 165: 410 417. 
25Kaufman MH. The chromosome complement of single-pronuclear haploid 
mouse embryos following activation by ethanol treatment. J Embryol 
Exp Morph 1982; 71: 139 154. 
26Dyban AP, Khozhai LI. Parthenogenetic development of ovulated mouse ova 
under the influence of ethyl alcohol. Bull Exp Biol Med 1980; 89: 528 
530.  
27Cuthbertson KSR. Parthenogenetic activation of mouse oocytes in vitro with 
ethanol and benzyl alcohol. J Exp Zool 1983; 226: 311 314. 
28O'Neill GT, Rolfe LR, Kaufman MH. Developmental potential and 
chromosome constitution of strontium-induced mouse 
parthenogenones. Mol Reprod Dev 1991; 30: 214 219. 
29Ma S-F, Liu X-Y, Miao D-Q, Han Z-B, Zhang X, Miao Y-L, Yanagimachi R, Tan 
J-H. Parthenogenetic activation of mouse oocytes by strontium 
chloride: a search for the best conditions. Theriogenology 2005; 64: 
1142 1157. 
30Cheng Y, Zhong Z, Latham KE. Strain-specific spontaneous activation during 
mouse oocyte maturation. Fertil Steril 2012; 98: 200 206. 
31Downs SM. Stimulation of parthenogenesis in mouse ovarian follicles by 
inhibitors of inosine monophosphate dehydrogenase. Biol Reprod 
1990; 43: 427 436. 
32Downs SM, Ya R, Davis CC. Role of PRKA throughout meiotic maturation in 
the mouse oocyte: evidence for promotion of polar body formation and 
suppression of premature activation. Mol Reprod Dev 2010; 77: 888 
899. 
33Kaufman MH, Howlett SK. The ovulation and activation of primary and 
secondary oocytes in LT/Sv strain mice. Gamete Res 1986; 14: 255 
264.  
34Eppig JJ, Wigglesworth K. Atypical maturation of oocytes of strain I/LnJ 
mice. Hum Reprod 1994; 9: 1136 1142. 
35Maleszewski M, Yanagimachi R. Spontaneous and sperm-induced activation 
of oocytes in LT/Sv strain mice. Dev Growth Differ 1995; 37: 679 685.  
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biology of Reproduction, Vol 88(3), No. 70 (2013). DOI. This article is © Society for the Study of Reproduction and 
permission has been granted for this version to appear in e-Publications@Marquette. Society for the Study of 
Reproduction does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from Society for the Study of Reproduction. 
26 
 
36Ciemerych MA, Kubiak JZ. Cytostatic activity develops during meiosis I in 
oocytes of LT/Sv mice. Dev Biol 1998; 200: 198 211. 
37Hampl A, Eppig JJ. Analysis of the mechanism(s) of metaphase I arrest in 
maturing mouse oocytes. Development 1995; 121: 925 933. 
38Hirao Y, Eppig JJ. Analysis of the mechanism(s) of metaphase I arrest in 
strain LT mouse oocytes: participation of MOS. Development 1997; 
124: 5107 5113. 
39Hirao Y, Eppig JJ. Analysis of the mechanism(s) of metaphase I-arrest in 
strain LT mouse oocytes: delay in the acquisition of competence to 
undergo the metaphase I/anaphase transition. Mol Reprod Dev 1999; 
54: 311 318. 
40Stevens LC, Varnum DS. The development of teratomas from 
parthenogenetically activated ovarian mouse eggs. Dev Biol 1974; 37: 
369 380. 
41Eppig JJ, Kozak LP, Eicher EM, Stevens LC. Ovarian teratomas in mice are 
derived from oocytes that have completed the first meiotic division. 
Nature 1977; 269: 517 518. 
42Artzt K, Calo C, Pinheiro EN, Dimeo-Talento A, Tyson FL. Ovarian 
teratocarcinomas in LT/Sv mice carrying t-mutations. Dev Genet 1987; 
8: 1 9. 
43Eppig JJ, Wigglesworth K, Varnum DS, Nadeau JH. Genetic regulation of 
traits essential for spontaneous ovarian teratocarcinogenesis in strain 
LT/Sv mice: aberrant meiotic cell cycle, oocyte activation, and 
parthenogenetic development. Cancer Res 1996; 56: 5047 5054. 
44Everett CA, Auchincloss CA, Kaufman MH, Abbott CM, West JD. Genetic 
influences on ovulation of primary oocytes in LT/Sv strain mice. 
Reproduction 2004; 128: 565 571. 
45Hardie DG. PRKA: a key regulator of energy balance in the single cell and 
the whole organism. Int J Obesity 2008; 32: S7 S12. 
46Downs SM, Hudson ER, Hardie DG. A potential role for AMP-activated 
protein kinase in meiotic induction in mouse oocytes. Dev Biol 2002; 
245: 200 212. 
47Downs SM, Chen J. Induction of meiotic maturation in mouse oocytes by 
adenosine analogs. Mol Reprod Dev 2006; 73: 1159 1168. 
48Chen J, Downs SM. AMP-activated protein kinase is involved in hormone-
induced mouse oocyte meiotic maturation in vitro. Dev Biol 2008; 313: 
47 57. 
49Ya R, Downs SM. Perturbing microtubule integrity blocks AMP-activated 
protein kinase-induced meiotic resumption in cultured mouse oocytes. 
Zygote 2013; ( in press). Published online ahead of print 16 November 
2012; DOI http://dx.doi.org/10.1017/S0967199412000457. 
50Whittingham D, Siracusa G. The involvement of calcium in the activation of 
mammalian oocytes. Exp Cell Res 1978; 113: 311 317. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biology of Reproduction, Vol 88(3), No. 70 (2013). DOI. This article is © Society for the Study of Reproduction and 
permission has been granted for this version to appear in e-Publications@Marquette. Society for the Study of 
Reproduction does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from Society for the Study of Reproduction. 
27 
 
51Vingtdeux V, Chandakka P, Zhao H, Davies P, Marambaud P. Small-molecule 
activators of AMP-activated protein kinase (PRKA), RSVA314 and 
RSVA405, inhibit adipogenesis. Mol Med 2011; 17: 1022 1030. 
52O'Neill GT, Kaufman PMH. Ovulation and fertilization of primary and 
secondary oocytes in LT/Sv strain mice. Gamete Res 1987; 18: 27 36. 
53Hupalowska A, Kalaszczynska I, Hoffmann S, Tsurumi C, Kubiak JZ, Polanski 
Z, Ciemerych MA. Metaphase I arrest in LT/Sv mouse oocytes involves 
the spindle assembly checkpoint. Biol Reprod 2008; 79: 1102 1110. 
54Waters JC, Chen RH, Murray AW, Salmon ED. Localization of Mad2 to 
kinetochores depends on microtubule attachment, not tension. J Cell 
Biol 1998; 141: 1181 1191.  
55Bos-Mikich A, Swann K, Whittingham DG. Calcium oscillations and protein 
synthesis inhibition synergistically activate mouse oocytes. Mol Reprod 
Dev 1995; 41: 84 90. 
56Alberio R, Zakhartchenko V, Motlik J, Wolf E. Mammalian oocyte activation: 
lessons from the sperm and implications for nuclear transfer. Int J Dev 
Biol 2001; 45: 797 809. 
57Eppig JJ. The relationship between parthenogenetic embryonic development 
and cumulus cell-oocyte intercellular coupling during oocyte meiotic 
maturation. Gamete Res 1982; 5: 229 237.  
58Eppig JJ, Wigglesworth K, Hirao Y. Metaphase I arrest and spontaneous 
parthenogenetic activation of strain LTXBO oocytes: chimeric 
reaggregated ovaries establish primary lesion in oocytes. Dev Biol 
2000; 224: 60 68. 
59MacNicol AM, Muslin AJ, Howard EL, Kikuchi A, MacNicol MC, Williams LT. 
Regulation of Raf-1-dependent signaling during early Xenopus 
development. Mol Cell Biol 1995; 15: 6686 6693. 
60Daar I, Paules RS, Vande Woude GF. A characterization of cytostatic factor 
activity from Xenopus eggs and c-most-transformed cells. J Cell Biol 
1991; 114: 329 335. 
61Tong C, Fan HY, Chen DY, Song XF, Schatten H, Sun QY. Effects of MEK 
inhibitor U0126 on meiotic progression in mouse oocytes: microtubule 
organization, asymmetric division and metaphase II arrest. Cell Res 
2003; 13: 375 383. 
62Zhang D, Pan L, Yang L-H, He X-K, Huang X-Y, Sun F-Z. Strontium 
promotes calcium oscillations in mouse meiotic oocytes and early 
embryos through InsP3 receptors, and requires activation of 
phospholipase and the synergistic action of InsP3. Hum Reprod 2005; 
20: 3053 3061. 
63Ross PJ, Beyhan Z, Iager AE, Yoon S-Y, Malcuit C, Schellander K, Fissore 
RA, Cibelli JB. Parthenogenetic activation of bovine oocytes using 
bovine and murine phospholipase C zeta. BMC Dev Biol 2008; 8: 1 12. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biology of Reproduction, Vol 88(3), No. 70 (2013). DOI. This article is © Society for the Study of Reproduction and 
permission has been granted for this version to appear in e-Publications@Marquette. Society for the Study of 
Reproduction does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from Society for the Study of Reproduction. 
28 
 
64Nakagawa K, Yamano S, Nakasaka H, Hinokio K, Yoshizawa M, Aono T. A 
combination of calcium ionophore and puromycin effectively produces 
human parthenogenones with one haploid pronucleus. Zygote 2001; 
9: 83 88. 
65Nakasaka H, Yamano S, Hinokio K, Nakagawa K, Yoshizawa M, Aono T. 
Effective activation method with A23187 and puromycin to produce 
haploid parthenogenones from freshly ovulated mouse oocytes. Zygote 
2000; 8: 203 208. 
66Lu Q, Zhao Y, Gao X, Li Y, Ma S, Mullen S, Critser JK, Chen Z-J. 
Combination of calcium ionophore A23187 with puromycin salvages 
human unfertilized oocytes after ICSI. Eur J Obstet Gynecol Reprod 
Biol 2006; 126: 72 76. 
67Cuthbertson KS, Whittingham DG, Cobbold PH. Free Ca2+ increases in 
exponential phases during mouse oocyte activation. Nature 1981; 294: 
754 757. 
68Winston NJ, McGuinness O, Johnson MH, Maro B. The exit of mouse oocytes 
from meiotic M-phase requires an intact spindle during intracellular 
calcium release. J Cell Sci 1995; 108: 143 151. 
69Chen R-H, Waters JC, Salmon ED, Murray AW. Association of spindle 
assembly checkpoint component XMad2 with unattached kinetochores. 
Science 1996; 274: 242 246. 
70Li Y, Benezra R. Identification of a human mitotic checkpoint gene: hsMad2. 
Science 1994; 274: 246 248. 
71Waters JC, Chen R-H, Murray AW, Gorbsky GJ, Salmon ED, Nicklas RB. 
Mad2 binding by phosphorylated kinetochores links error detection and 
checkpoint action in mitosis. Curr Biol 1996; 9: 649 652. 
72Zhang D, Ma W, Li YH, Hou Y, Li SW, Meng XQ, Sun XF, Sun QY, Wang WH. 
Intra-oocyte localization of MAD2 and its relationship with 
kinetochores, microtubules, and chromosomes in rat oocytes during 
meiotic. Biol Reprod 2004; 71: 740 748. 
73Wassmann K, Niault T, Maro B. Metaphase I arrest upon activation of the 
Mad2-dependent spindle checkpoint in mouse oocytes. Curr Biol 2003; 
13: 1596 1608. 
74Homer HA, McDougall A, Levasseur M, Murdoch AP, Herbert M. Mad2 is 
required for inhibiting securin and cyclin B degradation following 
spindle depolymerisation in meiosis I mouse oocytes. Reproduction 
2005; 130: 829 843. 
75Wang J-W, Lei Z-L, Nan C-L, Yin S, Liu J, Hou Y, Li Y-L, Chen D-Y, Sun Q-Y. 
RNA interference as a tool to study the function of MAD2 in mouse 
oocyte meiotic maturation. Mol Reprod Dev 2007; 74: 116 124. 
76Maciejewska Z, Polanski Z, Kisiel K, Kubiak JZ, Ciemerych M. Spindle 
assembly checkpoint-related failure perturbs early embryonic divisions 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biology of Reproduction, Vol 88(3), No. 70 (2013). DOI. This article is © Society for the Study of Reproduction and 
permission has been granted for this version to appear in e-Publications@Marquette. Society for the Study of 
Reproduction does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from Society for the Study of Reproduction. 
29 
 
and reduces reproductive performance of LT/Sv mice. Reproduction 
2009; 137: 931 942. 
77Hoffmann S, Krol M, Polanski Z. Spindle assembly checkpoint-related 
meiotic defect in oocytes from LT/Sv mice has cytoplasmic origin and 
diminishes in older females. Reproduction 2012; 144: 331 338. 
78Dumont J, Million K, Sunderland K, Rassinier P, Lim H, Leader B, Verlhac M-
H. Formin-2 is required for spindle migration and for the late steps of 
cytokinesis in mouse oocytes. Dev Biol 2007; 301: 254 265. 
79Pfender S, Kuznetsov V, Pleiser S, Kerkoff E, Shuh M. Spire-type actin 
nucleators cooperate with formin-2 to drive asymmetric oocyte 
division. Curr Biol 2011; 21: 955 960. 
80Lee JH, Koh H, Kim M, Kim Y, Lee SY, Karess RE, Lee S-H, Shong M, Kim J-
M, Kim J, Chung J. Energy-dependent regulation of cell structure by 
AMP-activated protein kinase. Nature 2007; 447: 1017 1020. 
81Thaiparambil JT, Eggers CM, Marcus AI. PRKA regulates mitotic spindle 
orientation through phosphorylation of myosin regulatory light chain. 
Mol Cell Biol 2012; 32: 3203 3217.  
82Vasquez-Martin A, Cufi S, Oliveras-Ferraros O, Menendez JA. Polo-like 
kinase 1 regulates activation of AMP-activated protein kinase (PRKA) 
at the mitotic apparatus. Cell Cycle 2012; 11: 2422 2426. 
83Albertini D, Eppig JJ. Unusual cytoskeletal and chromatin configurations in 
mouse oocytes that are atypical in meiotic progression. Dev Genet 
1995; 16: 13 19. 
84Viollet B, Athea Y, Mounier R, Guigas B, Zarrinpashneh E, Horman S, Lantier 
L, Hebrard S, Devin-Leclerc J, Beauloye C, Foretz M, Andreelli F, et al. 
PRKA: lessons from transgenic and knockout animals. Front Biosci 
2009; 14: 19 44.  
